HOME >> MEDICINE >> NEWS
PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms

(Philadelphia, PA) A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.

Thoracic aortic aneurysms (TAAs) occur when a section of the aorta the body's largest artery that carries blood out of the heart and into the organs of the body weakens and bulges outward like a balloon in the section of the artery that runs down the chest. Each year, more than 20,000 patients in the United States are diagnosed with TAA. Aortic aneurysms including thoracic and abdominal aortic aneurysms remain the 13th major cause of death in this country, accounting for nearly 15,000 deaths annually.

"The STARZ-TX2 trial is groundbreaking and excellent news for patients diagnosed with descending thoracic aortic aneurysms," says Dr. Fairman. "Surgery can be life-threatening for many of these patients and a 'wait-and-see' approach is often not an option because patients are at an increased risk of an aortic rupture. A non-surgical approach to treating this life-threatening disease could benefit thousands of lives."

The clinical trial, called STARZ-TX2 (Study of Thoracic Aortic Aneurysm Repair with the Zenith® TX2™ Thoracic TAA Endovascular Graft), is open to patients diagnosed with a descending thoracic aortic aneurysm. STARZ-TX2 will compare the outcomes of patients treated with open surgery to patients treated with the Zenith TX2 Thoracic TAA Endovascular Graft, manufactured by Cook Incorporated.

Specifically, the trial will assess device performance, as well as patient survival and aneurysm rupture rates in the surgical and endovascular treatment groups, over a 12-month period.

The trial will enroll 275 pat
'"/>

Contact: Ed Federico
ed.federico@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
16-Feb-2005


Page: 1 2

Related medicine news :

1. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
2. EuroVacc 02 HIV vaccine trial begins in February 2005
3. International trial of two microbicides begins
4. NIAID begins enrolling volunteers for novel HIV vaccine study
5. National Center for Children Exposed to Violence begins annual conference today
6. Enrollment begins for osteoarthritis initiative
7. Patients should be consulted before dialysis treatment begins
8. Clinical trial of new TB vaccine begins
9. First US tuberculosis vaccine trial in 60 years begins
10. UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
11. UB begins groundbreaking study on net effect on patients of HIV treatments, other drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature event, ... million people across hundreds of U.S. cities to raise awareness of suicide prevention. ...
(Date:9/2/2020)... ... 02, 2020 , ... RAM Technologies, Inc., the perennial leader ... Special Needs plans, is proud to support the 2020 National Conferences on Medicare, ... supporting the event as a sponsor and exhibitor and will be showcasing their ...
(Date:9/1/2020)... ... 01, 2020 , ... Dr. Kiran Gill is a Board ... the face, breast, and body. In 2018, she founded Aesthetics in Plastic Surgery ... aesthetic practice in Southwest Florida. Dr. Gill and her team offer surgical and ...
(Date:8/31/2020)... , ... August 31, 2020 , ... Want to get ... Cerebral Palsy Alliance Research Foundation (CPARF) is thrilled to launch its fourth annual STEPtember ... A fully virtual challenge, STEPtember meets everyone wherever they are at this moment — ...
(Date:8/31/2020)... ... , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this very ... of panic, experiencing deep anxiety, immense stress, and right now are needing serious relief from ... people on the planet are experiencing a great degree of emotional discomfort, be it fear ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... MYERS, Fla. (PRWEB) , ... August 27, 2020 , ... ... Board of Directors. Dr. Friedman is an adult and pediatric neuro-oncologist who serves on ... University and as an educator at Duke University Medical School. , Internationally recognized, Dr. ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... Services, Laboratory Testing division, expands its technology footprint with the addition of ... platforms available. With industry-leading biomarker solutions, complemented with traditional ligand-binding assays and ...
(Date:8/26/2020)... ... August 26, 2020 , ... Crossroads Hospice ... added CHC and CPCO to her name. , That’s thanks to her completion ... and the Certified Professional Compliance Officer (CPCO.) , The CHC is designed to ...
Breaking Medicine Technology:
Cached News: